dry eye disease

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease
Ophthalmology Times
Thu, 05/29/25 - 11:00 am
Alcon
FDA
Tryptyr
dry eye disease
FDA clears Grifols’ application for dry eye disease treatment
Clinical Trials Arena
Thu, 05/22/25 - 11:08 am
FDA
Grifols
dry eye disease
Aldeyra posts one hit, one miss for twice-rejected dry eye drug, plans FDA filing
Fierce Biotech
Tue, 05/6/25 - 10:21 am
Aldeyra Therapeutics
clinical trials
dry eye disease
reproxalap
Aldeyra’s dry eye drug suffers second FDA rejection, but imminent data spur hope of fast recovery
Fierce Biotech
Thu, 04/3/25 - 11:21 am
Aldeyra Therapeutics
dry eye disease
FDA
reproxalap
Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study
Fierce Biotech
Thu, 08/8/24 - 10:25 pm
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Palatin CEO claims ‘a positive study on its face,’ despite dry eye drug's primary endpoint miss
Fierce Biotech
Wed, 02/28/24 - 10:49 am
Palatin Technologies
dry eye disease
PL9643
clinical trials
Alcon’s dry eye drug achieves primary endpoints in Phase III trials
Clinical Trials Arena
Wed, 01/10/24 - 09:42 am
Alcon
dry eye disease
FDA
clinical trials
AR-15512
FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial
BioSpace
Wed, 11/29/23 - 12:03 pm
Aldeyra Therapeutics
reproxalap
FDA
dry eye disease
Aldeyra Anticipates FDA Rejection of Dry Eye Drug Following Regulatory Meeting
BioSpace
Tue, 10/17/23 - 10:17 am
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Bausch + Lomb Buys J&J’s Dry Eye Drops for $106.5M in Expansion of OTC Business
BioSpace
Thu, 07/6/23 - 11:32 am
Bausch + Lomb
dry eye disease
OTC
JNJ Vision
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Healio
Fri, 06/30/23 - 10:10 am
Bausch + Lomb
M&A
Novartis
Xiidra
dry eye disease
FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug
BioSpace
Fri, 05/19/23 - 10:23 am
Bausch + Lomb
Novaliq
Miebo
FDA
dry eye disease
Aldeyra reports positive data from dry eye disease therapy trial
Clinical Trials Arena
Wed, 03/1/23 - 10:08 am
Aldeyra Therapeutics
clinical trials
reproxalap
dry eye disease
Aldeyra’s sights set on November PDUFA
Endpoints
Tue, 02/7/23 - 11:57 am
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Aurinia Pharma, Sun Pharma enter into settlement agreement for dry eye disease drug
Medical Dialogues
Wed, 01/4/23 - 09:41 am
Aurinia Pharmaceuticals
Sun Pharma
dry eye disease
Cequa
Iveric hits again in pivotal eye disease program, keeping it on Apellis' tail in race to market
Fierce Biotech
Tue, 09/6/22 - 10:41 am
Iveric Bio
Apellis Pharmaceuticals
clinical trials
FDA
dry eye disease
geographic atrophy
Oyster Point plows ahead with 50 layoffs to focus on approved eye drug
Fierce Biotech
Fri, 08/12/22 - 10:26 am
Oyster Point Pharma
layoffs
dry eye disease
Aldeyra says eye drop clears three dry eye signals en route to FDA
Endpoints
Tue, 07/12/22 - 10:51 am
Aldeyra Therapeutics
dry eye disease
FDA
clinical trials
reproxalap
Oyster Point Laying Off 50 with Focus on Dry Eye Drug Launch
BioSpace
Thu, 06/30/22 - 11:05 am
Oyster Point Pharma
layoffs
dry eye disease
Tyrvaya
Aldeyra Prepares to Submit Dry Eye Disease Treatment Reproxalap to FDA
BioSpace
Thu, 06/9/22 - 10:22 am
Aldeyra Therapeutics
dry eye disease
reproxalap
clinical trials

Pages